The Maris Lab studies molecular and genetic mechanisms of neuroblastoma, a common childhood cancer. They aim to develop new diagnostic tests and targeted therapies, focusing on less toxic treatments and immunotherapy.
Dr. Patrick Grohar, director for Translational Research with the Center for Childhood Cancer Research, discusses development of a treatment for Ewing sarcoma.
New study aims to design future interventions to enhance cancer survivors’ well-being and appropriate healthcare utilization throughout their lifetime.
